Creatine Kinase Blockade Disrupts Energy Metabolism and Redox Homeostasis to Suppress Osteosarcoma Progression
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262311555 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Shingo Kishi und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pathology, School of Medicine, Nara Medical University, Kashihara 634-8521, Japan. Hauptthemen laut MEDLINE: Osteosarcoma, Energy Metabolism, Homeostasis, Bone Neoplasms. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education, Culture, Sports, Science and Technology, MEXT KAKENHI.
Abstract (Originalsprache)
Osteosarcoma is the most common primary malignant bone tumor in adolescents and young adults; yet survival outcomes have remained stagnated for decades, underscoring the urgent need for new therapeutic strategies. Creatine kinase (CK)—comprising cytosolic CKB and mitochondrial CK—maintains malignant behaviors by supporting high-energy phosphate transfer through the phosphocreatine (pCr) shuttle. Here, we pharmacologically inhibited CK activity in osteosarcoma models and evaluated proliferation, cell death modalities, mitochondrial function, stemness, motility, and tumor behavior. CK blockade consistently suppressed growth and clonogenicity and induced apoptosis as the predominant mode of death. It impaired ATP buffering capacity and disturbed mitochondrial homeostasis, accompanied by reduced expression of stemness-associated markers and diminished migration and invasion. In mouse models, CK inhibition significantly restrained tumor progression and dissemination. These results indicate that disabling the CK-pCr energy-buffering system reprograms cellular energetics toward apoptosis and less aggressive phenotypes. Our findings support targeting the CK pathway as a tractable metabolic vulnerability and a rational partner for cytotoxic regimens, with pathway-specific signaling alterations representing downstream consequences of central energetic collapse.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pathology, School of Medicine, Nara Medical University, Kashihara 634-8521, Japan.
- Department of Pathology, School of Medicine, Kansai Medical University, Hirakata 573-1010, Japan.
- Department of Soft Tissue Sarcomas, School of Medicine, Nara Medical University, Kashihara 634-8522, Japan.
ORCID-Profile: Ryoichi Nishida, Kanya Honoki, Hiroki Kuniyasu
Förderung
- Ministry of Education, Culture, Sports, Science and Technology
- MEXT KAKENHI
Zitieren
APA
Kishi, S., Sasaki, R., Fujiwara-Tani, R., Ohmori, H., Luo, Y., Fujii, K., Sasaki, T., Goto, K., Miyagawa, Y., Kawahara, I., Nishida, R., Nukaga, S., Nishiguchi, Y., Ogata, R., Honoki, K., & Kuniyasu, H. (2025). Creatine Kinase Blockade Disrupts Energy Metabolism and Redox Homeostasis to Suppress Osteosarcoma Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262311555
Vancouver
Kishi S, Sasaki R, Fujiwara-Tani R, Ohmori H, Luo Y, Fujii K, et al. Creatine Kinase Blockade Disrupts Energy Metabolism and Redox Homeostasis to Suppress Osteosarcoma Progression. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262311555
BibTeX
@article{Kishi2025,
author = {Kishi, Shingo and Sasaki, Rika and Fujiwara-Tani, Rina and Ohmori, Hitoshi and Luo, Yi and Fujii, Kiyomu and Sasaki, Takamitsu and Goto, Kei and Miyagawa, Yoshihiro and Kawahara, Isao and Nishida, Ryoichi and Nukaga, Shota and Nishiguchi, Yukiko and Ogata, Ruiko and Honoki, Kanya and Kuniyasu, Hiroki},
title = {Creatine Kinase Blockade Disrupts Energy Metabolism and Redox Homeostasis to Suppress Osteosarcoma Progression},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262311555}
}
EUVIMED